S Watanabe, A D Renzetti, A Bigler. Show Affiliations »
Abstract
Entities: Disease Species
Mesh： See more » Administration, OralAdrenergic beta-Agonists/therapeutic useAdultAerosolsAgedAirway Resistance/drug effectsAmino Alcohols/therapeutic useAsthma/drug therapyBronchitis/drug therapyBronchodilator Agents/administration & dosageBronchodilator Agents/therapeutic useBronchospirometryCatechols/therapeutic useFemaleHistamine H1 Antagonists/therapeutic useHumansMaleMiddle AgedPhenylephrine/administration & dosagePhenylephrine/therapeutic usePlethysmography, Whole BodyPrednisone/administration & dosagePrednisone/therapeutic usePropylamines/therapeutic usePulmonary Emphysema/drug therapyPulmonary Ventilation/drug effectsPyridines/therapeutic useRadioisotopesRespiratory Function TestsXenon
Substances： See more » Adrenergic beta-AgonistsAerosolsAmino AlcoholsBronchodilator AgentsCatecholsHistamine H1 AntagonistsPropylaminesPyridinesRadioisotopesPhenylephrineXenonPrednisone
Year: 1972 PMID： 4404156 DOI： 10.1164/arrd.1972.106.3.392
Source DB: PubMed Journal: Am Rev Respir Dis ISSN： 0003-0805